| GeneLibs

题目:: Role of platelets in cancer and cancer-associated thrombosis: Experimental and clinical evidences.
作者:: Mezouar(Soraya),Frère(Corinne),Darbousset(Roxane),Mege(Diane),Crescence(Lydie),Dignat-George(Françoise),Panicot-Dubois(Laurence),Dubois(Christophe)
状态:: 发布时间2016-02-26 , 更新时间 2016-02-26
期刊:: Thromb Res
摘要:: The primary hemostatic function of platelets has been recognized for more than a century, but increasing experimental and clinical evidences suggest that platelets are also important mediators of cancer. Cancer indeed influences platelet physiology, and activated platelets participate in each step of cancer development by promoting tumor growth, angiogenesis, metastasis, and cancer-associated thrombosis. Based on both the results of numerous experimental models addressing the involvement of platelets in cancer progression and the results of epidemiologic studies on the use of anti-platelet drugs to prevent cancer, platelets have been proposed as a potential target to reduce the short-term risk of cancer, cancer dissemination and cancer mortality. However, the cancer-associated thrombosis and the risk of bleeding due to anti-platelet drugs are not enough evaluated in experimental models. Therefore, the interesting contribution of platelets to cancer and cancer-associated thrombosis requires the standardization of preclinical and clinical models.
语言:: eng
DOI:: 10.1016/j.thromres.2016.01.006

文献库文献相关信息